🕵️ AIM Immunotech Inc. ($AIM)
SEC insider & ownership activity, last 12 months · CIK 946644 · every row links its SEC filing
Over the last 12 months insiders bought $8K with no open-market selling against it. Thomas K. Equels bought $8K in discretionary trades (Sep). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $8K (3 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Thomas K. Equels | 3 | $8K | 0 | – | Sep 16, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| ORCA Capital AG | 9.9% | 13G | May 12, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Sep 8, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Sep 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 8, 2026 | filing ↗ |
| Material agreement (1.01) | Sep 3, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Sep 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 3, 2026 | filing ↗ |
| Material agreement (1.01) | Aug 31, 2026 | filing ↗ |
| Agreement terminated (1.02) | Aug 31, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 31, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 11, 2026 | filing ↗ |
| Earnings (2.02) | Aug 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 31, 2026 | filing ↗ |
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 (5.08) | Jul 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 31, 2026 | filing ↗ |
| Agreement terminated (1.02) | Jul 31, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jul 15, 2026 | filing ↗ |
| Other events (8.01) | Jun 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 12, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 9, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 9, 2026 | filing ↗ |
| Other events (8.01) | Jun 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 9, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 9, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 4, 2026 | filing ↗ |
| Material agreement (1.01) | May 20, 2026 | filing ↗ |